Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapy.
Salehiabar M, Ghaffarlou M, Mohammadi A, Mousazadeh N, Rahimi H, Abhari F, Rashidzadeh H, Nasehi L, Rezaeejam H, Barsbay M, Ertas YN, Nosrati H, Kavetskyy T, Danafar H.
Salehiabar M, et al. Among authors: mousazadeh n.
J Control Release. 2023 Jan;353:850-863. doi: 10.1016/j.jconrel.2022.12.004. Epub 2022 Dec 17.
J Control Release. 2023.
PMID: 36493951